한국어
English
日本語
中文(简体)
Renalid Tablet (Lenalidomide)
2.5mg
Tablet · Prescription medication
Samyang Biopharm Co., Ltd.
Lenalidomide anhydrous is an antineoplastic agent used in the treatment of multiple myeloma.
MFDS ingredient code M266671
Lenalidomide anhydrous is a synthetic compound with immunomodulatory action, primarily used in the treatment of blood cancers such as multiple myeloma. This ingredient plays a role in inhibiting the growth of cancer cells and enhancing the immune system.
Lenalidomide anhydrous changes the environment around cancer cells to prevent their proliferation and enhances the activity of immune cells to help attack the cancer cells. It also inhibits angiogenesis, reducing the blood supply needed for tumor growth.
Approved uses differ by product. Check each product's information for its actual use.
Lenalidomide is similar to existing thalidomide class drugs, but it is an immunomodulator that reduces side effects while increasing therapeutic efficacy. It is sometimes used in combination with other anticancer drugs and is characterized by its specialized action on the immune system.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.